BCK Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
Other funds holding CCXI
BCK Capital Management's CCXI Position: Q4 2022 in Review
BCK Capital Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 17,500 shares — an estimated $904K sold.
BCK Capital Management first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $904K in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- BCK Capital Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- BCK Capital Management sold 17,500 ChemoCentryx, Inc. shares in Q4 2022, an estimated $904K.
- BCK Capital Management first reported a position in ChemoCentryx, Inc. in Q3 2022 and held it in 1 quarter.
- BCK Capital Management's ChemoCentryx, Inc. position peaked at $904K in Q3 2022.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on BCK Capital Management's 13F filing for Q4 2022, filed 9 Feb 2023.